Phio Pharmaceuticals Corp.

PHIO · Pharmaceutical Preparations

Latest available SEC filing: 10-Q ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • PHIO · 71880W501 - Common Stock, $0.0001 par value per share
  • PHIO · 71880W204 - COM
  • PHIO · 71880W303 - COM NEW
  • PHIO · 71880W402 - COM
Company details and SEC sources

CIK 0001533040 · SEC filing index. Filing dates describe disclosures, not live market data.

At a glance Names, identifiers, and filing context for this profile. 2 identity fields
Business address
411 Swedeland Road, Suite 23 1080, King Of Prussia, PA, 19406
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
DE
Fiscal year end
31 December
Former names on EDGAR
RXi Pharmaceuticals Corp (to 14 Nov 2018)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .